· 1 min read
Did you know that inadequate investigations are the most often cited issue in FDA warning letters? This webinar from expert Andy Barnett addresses the most frequent investigation gaps cited by the FDA and provides a framework for improving investigation reports. We share the results from our review of 171 warning letters issued since 2013 and introduce a structured approach to writing and reviewing investigation reports. The webinar also includes a recent NSF case study.